DUBs regulate key signaling pathways such as NF-κB, PI3K/Akt/mTOR, and MAPK, and are implicated in a wide range of diseases, including cancer, neurodegenerative disorders, cardiovascular conditions, inflammation, and developmental abnormalities. This evidence concerns the gene AKT1 and cancer.